This further verifies our conclusion that elevated CENPL can independently predict poor prognosis of HCC, and to some extent predict the efficacy of some immunotherapy, which provides a direction for new immunotherapy methods. This evidence concerns the gene CENPL and hepatocellular carcinoma.